Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Wolfe

Showing results (71-80 of 202) with videos related to

Pageof 21
Sort By:
Arthritis and Rheumatism|February 1, 2006
Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapyFrederick Wolfe, Liron Caplan, Kaleb Michaud
The Journal of Rheumatology|June 2, 2004
Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical careFrederick Wolfe, Sean Zhao, Dan Pettitt
The Journal of Rheumatology|June 9, 2005
Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patientsNancy Walker, Kaleb Michaud, Frederick Wolfe
The Journal of Rheumatology|December 7, 2005
A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II)Frederick Wolfe, Kaleb Michaud, Theodore Pincus
The Journal of Rheumatology|September 6, 2007
The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disabilityFrederick Wolfe, Saralynn Allaire, Kaleb Michaud
Arthritis and Rheumatism|October 12, 2004
Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaireFrederick Wolfe, Kaleb Michaud, Theodore Pincus
The Journal of Rheumatology|July 5, 2005
Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritisFrederick Wolfe, Kaleb Michaud, Theodore Pincus
The Journal of Rheumatology|April 1, 2005
Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritisFrederick Wolfe, Kaleb Michaud, Vibeke Strand
Arthritis Care & Research|November 17, 2010
Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patientsKaleb Michaud, Gene Wallenstein, Frederick Wolfe
ACR Open Rheumatology|April 21, 2022
Fibromyalgia criteria and anomalous results: comment on the article by Ghavidel-Parsa et alFrederick Wolfe, Johannes J Rasker, Winfried Häuser
Pageof 21

Showing results (71-80 of 202) with videos related to

Sort By:
Pageof 21
Arthritis and Rheumatism|February 1, 2006
Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapyFrederick Wolfe, Liron Caplan, Kaleb Michaud
The Journal of Rheumatology|June 2, 2004
Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical careFrederick Wolfe, Sean Zhao, Dan Pettitt
The Journal of Rheumatology|June 9, 2005
Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patientsNancy Walker, Kaleb Michaud, Frederick Wolfe
The Journal of Rheumatology|December 7, 2005
A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II)Frederick Wolfe, Kaleb Michaud, Theodore Pincus
The Journal of Rheumatology|September 6, 2007
The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disabilityFrederick Wolfe, Saralynn Allaire, Kaleb Michaud
Arthritis and Rheumatism|October 12, 2004
Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaireFrederick Wolfe, Kaleb Michaud, Theodore Pincus
The Journal of Rheumatology|July 5, 2005
Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritisFrederick Wolfe, Kaleb Michaud, Theodore Pincus
The Journal of Rheumatology|April 1, 2005
Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritisFrederick Wolfe, Kaleb Michaud, Vibeke Strand
Arthritis Care & Research|November 17, 2010
Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patientsKaleb Michaud, Gene Wallenstein, Frederick Wolfe
ACR Open Rheumatology|April 21, 2022
Fibromyalgia criteria and anomalous results: comment on the article by Ghavidel-Parsa et alFrederick Wolfe, Johannes J Rasker, Winfried Häuser
Pageof 21